Literature DB >> 28426472

Imaging in Patients with Crohn's Disease: Trends in Abdominal CT/MRI Utilization and Radiation Exposure Considerations over a 10-Year Period.

Hamed Kordbacheh1, Vinit Baliyan, Jessica Serrao, Michael S Gee, Vijay Yajnik, Dushyant V Sahani, Avinash R Kambadakone.   

Abstract

PURPOSE: To study the trends in utilization of computed tomography (CT) and magnetic resonance imaging (MRI) in patients with Crohn's disease and to evaluate changes in CT radiation exposure over a 10-year period.
METHODS: In this institutional review board-approved single-institution retrospective study, we included patients who underwent CT and MRIs for evaluation of Crohn's disease between 2006 and 2015. A total of 3196 CTs and 1924 MR scans were performed in 2156 patients (mean age: 34.8 ± 17.71 yr; range: 3-91 yr) for initial diagnosis or follow-up of Crohn's disease between 2006 and 2015. Trends in CT/MR utilization was assessed by comparing the volume of CT/MRI studies performed each year. The changes in CT radiation exposure over the study period were estimated and compared.
RESULTS: The annual combined CT/MR utilization demonstrated a 1.9-fold rise over the last decade (2006: n = 358, 2015: n = 681, P < 0.001, r = 0.96). It was predominantly because of a substantial growth (9.2-fold increase) in the MR scan volume (2006: n = 37, 2015: n = 341, P < 0.001, r = 0.93), whereas CT volume did not show significant change (2006: n = 321, 2015: n = 340, P = 0.6). Over this same period, there was a 59.4% reduction in mean radiation exposure (2006: CT dose indexvol 16.9 ± 7.1 mGy, 2015: CT dose indexvol 6.87 ± 4.62 mGy, P < 0.001).
CONCLUSIONS: A 9-fold growth in annual MR scan volume contributed to a nearly 2-fold rise in yearly cross-sectional imaging utilization in Crohn's patients between 2006 and 2015. Rising trend in imaging utilization paralleled a 60% reduction of CT radiation exposure.

Entities:  

Mesh:

Year:  2017        PMID: 28426472     DOI: 10.1097/MIB.0000000000001088

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  7 in total

Review 1.  Magnetic resonance enterography evaluation of Crohn disease activity and mucosal healing in young patients.

Authors:  Amirkasra Mojtahed; Michael S Gee
Journal:  Pediatr Radiol       Date:  2018-08-04

2.  Unscheduled Radiologic Examination Orders in the Electronic Health Record: A Novel Resource for Targeting Ambulatory Diagnostic Errors in Radiology.

Authors:  Ronilda Lacson; Michael J Healey; Laila R Cochon; Romeo Laroya; Keith D Hentel; Adam B Landman; Sunil Eappen; Giles W Boland; Ramin Khorasani
Journal:  J Am Coll Radiol       Date:  2020-01-16       Impact factor: 5.532

3.  Multicentric study of patients receiving 50 or 100 mSv in a single day through CT imaging-frequency determination and imaging protocols involved.

Authors:  Madan M Rehani; John Heil; Vinit Baliyan
Journal:  Eur Radiol       Date:  2021-03-08       Impact factor: 5.315

4.  Factors influencing cumulative radiation dose from percutaneous intra-abdominal abscess drainage in the setting of inflammatory bowel disease.

Authors:  Thomas J An; Azadeh Tabari; Michael S Gee; Colin J McCarthy
Journal:  Abdom Radiol (NY)       Date:  2020-11-25

5.  Assessment of Imaging Features of Crohn's Disease with MR Enterography.

Authors:  Mehmet Onay; Ayşe Erden; Ali Burak Binboğa; Çetin Murat Altay; Murat Törüner
Journal:  Turk J Gastroenterol       Date:  2021-08       Impact factor: 1.852

6.  The combination of a reduction in contrast agent dose with low tube voltage and an adaptive statistical iterative reconstruction algorithm in CT enterography: Effects on image quality and radiation dose.

Authors:  Cui Feng; Di Zhu; Xianlun Zou; Anqin Li; Xuemei Hu; Zhen Li; Daoyu Hu
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

7.  Classifying Safety Events Related to Diagnostic Imaging From a Safety Reporting System Using a Human Factors Framework.

Authors:  Ronilda Lacson; Laila Cochon; Ivan Ip; Sonali Desai; Allen Kachalia; Jack Dennerlein; James Benneyan; Ramin Khorasani
Journal:  J Am Coll Radiol       Date:  2018-12-07       Impact factor: 5.532

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.